Liraglutide as add-on therapy to insulin in type 2 diabetes mellitus: a retrospective, observational study from a daily clinical practice setting in Switzerland.

Introduction: In most patients with type 2 diabetes mellitus (T2DM) and progressive beta-cell insufficiency, insulin therapy is required to achieve sufficient glycemic control. However, insulin therapy may lead to weight gain and increasing risk of hypoglycemia. Glucagon-like peptide-1 receptor agonists are being used as add-on therapy to insulin with favorable metabolic effects.

Prevalence and morphology of supernumerary teeth in the population of a Swiss community. Short communication.

The objective of the study was to determine the current prevalence of supernumerary teeth (PST) in the population of a Swiss community. 3,004 orthopantomograms (OPTs) routinely produced during the annual school dental examinations in the Winterthur municipality from 1990 to 2005 served as the study basis (average age 9.45 years, 1391 girls, 1613 boys, age range 6-15 years).

[19-year-old patient with adrenal cortex insufficiency--only the tip of the iceberg. Polyendocrine autoimmune syndrome type II (Schmidt syndrome)].

We report on a 19-year-old woman with polyglandular autoimmune syndrome type II (APS II). She was diagnosed with addison's disease and hypothyroidism due to chronic autoimmune thyroiditis. Her mother had celiac disease and her brohter had diabetes mellitus typ 1.